By Oliver Hirt and Marleen Kaesebier ZURICH, Sept 10 (Reuters) – A major shareholder in Novartis has called for a shake-up of the Swiss drugmaker's board to improve corporate governance after its
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)